Remove Litigation Remove Marketing Remove Patent Infringement
article thumbnail

Google sues Sonos for Patent Infringement – Again

IPilogue

Efficient infringement refers to Google’s bet that the cost of contesting and paying off patent infringement lawsuits will be significantly less than the profits earned from sale of the technology. Sonos also says that Google has been undercutting its prices to crowd competitors out of the market. The present suit.

article thumbnail

Litigation as a Source of Profit? Non-Practicing Entities and Patent Litigation

IPilogue

Litigation is almost always recommended to be avoided , whether because of the sheer amount of time needed to get a court date, the expensive costs for the client and law firm, or the risks associated with receiving an unfavorable judgement. They do not practice, develop, manufacture, or otherwise commercialize the patent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guest Post: Third-Party Litigation Funding: Disclosure to Courts, Congress, and the Executive

Patently-O

Stroud is General Counsel at Unified Patents – an organization often adverse to litigation-funded entities. [1] Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. Patent assertion finance today is a multibillion-dollar business. [2]

article thumbnail

mRNA Patent Litigation: The ‘Sport of Kings’

SpicyIP

Moderna recently sued Pfizer alleging patent infringement of three out of eight patents that cover its Covid 19 vaccine (Spikevax). Moderna’s patent infringement lawsuit is a revenue seeking activity since Moderna wants fair compensation but does not want to remove Comirnaty from the market. Image from here.

article thumbnail

Patent Linkage Litigation in China: A Two-Year Review

IP Tech Blog

On June 1, 2021, the Fourth Amendment to the Chinese Patent Law became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.

article thumbnail

Another Drop in the Bucket: Delhi High Court’s Interim Injunction Denial for Vifor in FCM Patent Infringement

SpicyIP

Adding another leaf to the FCM patent litigation saga, the Delhi High Court on September 19 refused to grant an interim injunction to Vifor considering the launch of the Biological E’s product in the market. She is keenly interested in Intellectual Property Law, Technology Law, and Corporate Law.

article thumbnail

Tier I, Tier II, Time for Experts; The Curious Case of Scientific Advisers, Party Expert and Two Tiered Confidentiality Club 

SpicyIP

This case pertains to patent infringement concerning two process patents related to the fungicide Azoxystrobin. filed a suit against the defendant, GSP Crop Science Private Limited, alleging infringement of the following patents the Indian Patent No. Two more interesting issues arose in this case.